President Trump's recent executive orders (EOs) and actions have significantly impacted healthcare in the U.S., with notable changes affecting hospitals, drug pricing, gender-affirming care, and international health relations. Key measures address issues from prescription costs to global health organization participation. Click here for article.
Drug Pricing: Reversed Biden's initiatives aimed at reducing Medicare and Medicaid prescription drug costs, while maintaining some protections like insulin cost caps.
Gender-Affirming Care: Restricted federal funding for gender-affirming care for minors, affecting hospitals' ability to provide such services.
The ACA: Rescinded Biden's special enrollment period for ACA plans and efforts to simplify enrollment.
U.S. WHO Exit: Pulled the U.S. from the World Health Organization, citing its handling of the COVID-19 pandemic and other crises.
Comments